LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Velocity Pharmaceutical Development LLC
Headquarters:
San Francisco, CA, United States
Website:
http://www.vpd.net
Year Founded:
2011
Status:
Private
BioCentury
|
Nov 15, 2019
Financial News
Atomwise JV raises $14.5M series A to advance AI-discovered candidates
Read More
BioCentury
|
May 30, 2016
Company News
Astellas, Thunderbolt deal
Read More
BioCentury
|
Jul 13, 2015
Strategy
Baxalta's blueprint
Baxter spinout Baxalta is engaging patients to build its portfolio
Read More
BioCentury
|
Jun 8, 2015
Company News
Velocity Pharmaceutical Development, Vitesse Biologics, Baxter, Mayo Clinic deal
Read More
BioCentury
|
Jan 5, 2015
Clinical News
Serlopitant: Phase II data
Read More
BioCentury
|
Jun 30, 2014
Clinical News
Serlopitant: Phase II started
Read More
BioCentury
|
Mar 10, 2014
Finance
Innovator capital rationing
Actual financing data paint different picture of biotech's 'valley of death'
Read More
BioCentury
|
Sep 2, 2013
Finance
Gaining Velocity
Why Velocity partnered with Remeditex to invest in POC opportunities
Read More
BioCentury
|
Sep 2, 2013
Company News
Tigercat, Velocity Pharmaceutical Development, Velocity Pharmaceutical Holdings LLC deal
Read More
BioCentury
|
Aug 19, 2013
Company News
Velocity, Remeditex partner to evaluate assets
Read More
Items per page:
10
1 - 10 of 12